A068760 Stock Overview
Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Celltrion Pharm, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩91,900.00 |
52 Week High | ₩133,300.00 |
52 Week Low | ₩57,714.29 |
Beta | 0 |
1 Month Change | -17.73% |
3 Month Change | -7.27% |
1 Year Change | 13.79% |
3 Year Change | -29.25% |
5 Year Change | 91.06% |
Change since IPO | 699.14% |
Recent News & Updates
Does Celltrion Pharm (KOSDAQ:068760) Deserve A Spot On Your Watchlist?
May 05Do Institutions Own Celltrion Pharm, Inc. (KOSDAQ:068760) Shares?
Mar 03These 4 Measures Indicate That Celltrion Pharm (KOSDAQ:068760) Is Using Debt Reasonably Well
Feb 02Recent updates
Does Celltrion Pharm (KOSDAQ:068760) Deserve A Spot On Your Watchlist?
May 05Do Institutions Own Celltrion Pharm, Inc. (KOSDAQ:068760) Shares?
Mar 03These 4 Measures Indicate That Celltrion Pharm (KOSDAQ:068760) Is Using Debt Reasonably Well
Feb 02Do Celltrion Pharm's (KOSDAQ:068760) Earnings Warrant Your Attention?
Dec 29Celltrion Pharm, Inc.'s (KOSDAQ:068760) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Nov 24Shareholder Returns
A068760 | KR Pharmaceuticals | KR Market | |
---|---|---|---|
7D | -4.6% | -1.0% | -2.4% |
1Y | 13.8% | 4.5% | 1.9% |
Return vs Industry: A068760 exceeded the KR Pharmaceuticals industry which returned 4.5% over the past year.
Return vs Market: A068760 exceeded the KR Market which returned 1.9% over the past year.
Price Volatility
A068760 volatility | |
---|---|
A068760 Average Weekly Movement | 6.3% |
Pharmaceuticals Industry Average Movement | 4.7% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 12.0% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A068760's share price has been volatile over the past 3 months.
Volatility Over Time: A068760's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1976 | n/a | Jung-su Seo | www.celltrionph.com |
Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies.
Celltrion Pharm, Inc. Fundamentals Summary
A068760 fundamental statistics | |
---|---|
Market cap | ₩3.81t |
Earnings (TTM) | ₩26.03b |
Revenue (TTM) | ₩274.73b |
0.0x
P/E Ratio0.0x
P/S RatioIs A068760 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A068760 income statement (TTM) | |
---|---|
Revenue | ₩274.73b |
Cost of Revenue | ₩193.89b |
Gross Profit | ₩80.84b |
Other Expenses | ₩54.82b |
Earnings | ₩26.03b |
Last Reported Earnings
Mar 31, 2021
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did A068760 perform over the long term?
See historical performance and comparison